NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Termedia Publishing House Ltd. 2009

Míreanna comhchosúla

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
de réir: Amandeep Aujla, et al.
Foilsithe / Cruthaithe: (2019-04-01)

Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
de réir: Ali Ghassemi, et al.
Foilsithe / Cruthaithe: (2016-06-01)

Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
de réir: Miguel Enrique Cuéllar Mendoza, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
de réir: Betül Sevinir, et al.
Foilsithe / Cruthaithe: (2011-03-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
de réir: Betül Sevinir, et al.
Foilsithe / Cruthaithe: (2011-03-01)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
de réir: Seth E. Karol, et al.
Foilsithe / Cruthaithe: (2021-07-01)

NK cell compartment in patients with coronary heart disease.
de réir: Hak, Ł, et al.
Foilsithe / Cruthaithe: (2007)

Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
de réir: Darshana Jani, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
de réir: Škorić Biljana, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
de réir: Marlise R. Luskin, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Changes in number of NK cells after one year from coronary artery bypass graft
de réir: Hak, L, et al.
Foilsithe / Cruthaithe: (2009)

2448 The effect of allopurinol on pediatric patients undergoing maintenance chemotherapy for acute lymphoblastic leukemia or lymphoblastic lymphoma
de réir: Mariam M. Bhuiyan, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Linfoma No Hodgkin extranodal NK/T nasal Extranodal Non-Hodgkin NK/T nasal Lymphoma
de réir: Enrique Muñoz Hernández, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
de réir: Gustavo de Oliveira Canedo, et al.
Foilsithe / Cruthaithe: (2025-02-01)

TO THE PROBLEM OF RADIATION-INDUCED CARCINOGENESIS AFTER TREATMENT OF HODGKIN’S LYMPHOMA AND ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND ADOLESCENTS
de réir: O. I. Scherbenko, et al.
Foilsithe / Cruthaithe: (2016-02-01)

Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia
de réir: Le Jie Lee, et al.
Foilsithe / Cruthaithe: (2022-01-01)

The importance of intensive chemotherapy for advanced Hodgkin lymphoma in children
de réir: E.S. Belyaeva, et al.
Foilsithe / Cruthaithe: (2020-06-01)

NK cell compartment in patients with coronary heart disease
de réir: Siebert Janusz, et al.
Foilsithe / Cruthaithe: (2007-05-01)

Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
de réir: Andrew D. Hughes, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
de réir: Luke Maese, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Combination chemotherapy for Hodgkin lymphoma
de réir: Alison J. Moskowitz
Foilsithe / Cruthaithe: (2024-08-01)

Precursor NK cell lymphoblastic leukemia/lymphoma - report of a case with literature review
de réir: Sonal Jain, et al.
Foilsithe / Cruthaithe: (2014-08-01)

The Effect of a New Glucose–Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma Cell Lines
de réir: Marta Woźniak, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin’s lymphoma
de réir: Jiwei Song, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma
de réir: Andreas Engert, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy
de réir: Ling Ling Chua, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma
de réir: Siba El Hussein, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
de réir: Ardeshir Ghavamzadeh, et al.
Foilsithe / Cruthaithe: (2012-04-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
de réir: Taher Entezari-Maleki, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia
de réir: Keyu Liu, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Genetic Variations of Tumor Necrosis Factor –α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients
de réir: Hajar Nasiri, et al.
Foilsithe / Cruthaithe: (2013-09-01)

Hyperglycemia during induction chemotherapy of pediatric acute lymphoblastic leukemia
de réir: Shwetha Seetharam, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Clinical Profile and Induction Outcome of Children with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
de réir: Awais Arshed, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy
de réir: Zhao J, et al.
Foilsithe / Cruthaithe: (2015-06-01)

Participation in Physical Activity and Physical Education in School Among Children With Acute Lymphoblastic Leukemia After Intensive Chemotherapy
de réir: Hamidah Alias, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Ikaros Deletions among Bulgarian Patients with Acute Lymphoblastic Leukemia/Lymphoma
de réir: Stefan Lozenov, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia
de réir: Mako Ikeda, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma
de réir: Linu A Jacob, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma
de réir: Baldeep Wirk
Foilsithe / Cruthaithe: (2010-01-01)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
de réir: Guillermo eGervasini, et al.
Foilsithe / Cruthaithe: (2012-11-01)